Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CinnoVex home page
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Rare onset symptoms in multiple sclerosis.
Differential transcriptional response profiles in human myeloid cell populations.
Voiding Dysfunction in Multiple Sclerosis.
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Intrathecal interferon reduces exacerbations of multiple sclerosis.
The "poison chair" treatment for multiple sclerosis.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Policy: NIH to balance sex in cell and animal studies.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
[Prevalence of multiple sclerosis in the Region of Murcia].
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis

Pages